Another line of studies showed that blocking VEGFR-3 signaling in vivo with an anti-VEGFR-3 neutralizing antibody inhibits tumor-associated lymphangiogenesis [8] and lymphatic regeneration during wound repair [9] in adults, indicating the involvement of VEGFR-3 in adult lymphangiogenesis. This evidence concerns the gene FLT4 and neoplasm.